Make your money go further for just 25p per day

Craneware is back on track

04/09/2019 · Craneware PLC (CRW) 

AIM Financial Results UK

Craneware robot in hospital setting

Craneware is in our portfolio because it offers excellent growth opportunities in the US. Reliable, recurring revenue – a key characteristic of a software company – helps to justify its slightly stretched valuation. This is the ultimate guide to news updates from the AIM gem.


Hospitals can be great customers of software companies. They’re loyal to their providers (switching patient data to a new platform is not easy) and are always looking for ways to improve efficiency by adding extra products and subscriptions. That is why Craneware (LON: CRW) – provider of specialist software solutions to US hospitals – has long been a darling of AIM, with a dazzling valuation to match (at its 52-week peak in September 2018, shares traded on 65 times forecast earnings).

Craneware has historically gone some way to justifying its valuation with its reliability. Every year at the interim stage, management…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE

Become a Champion Investor for just £90 a year.
 
 

START FREE TRIAL

More on Craneware PLC

How can Hotel Chocolat keep defying retail’s challenges?

24/01/2020 · Company Insights

Strong results from the chocolate makers have justified a stretched valuation, but others haven’t been so…


US strength helped our Ultimate Stocks portfolio beat UK gloom in Q3

01/10/2019 · Portfolio

A summer of political turmoil (and its knock-on impact on the UK stock markets) has hampered…